Clinical Trials Logo

Clinical Trial Summary

The important evidence of coronary microcirculation for the management of patients with coronary artery disease is only increasing. Thus, in recent years, a number of studies have shown that the demonstration of coronary microvascular disease (CMVD) contributes to cardiovascular morbidity and mortality increases independently of epicardial damage. This has been shown in stable coronary artery disease with screening for CMVD when there is no significant epicardial involvement and allowing the implementation of an adapted treatment then reducing the symptoms and improving the quality of life of our patients. (1). The prognostic nature of CMVD has also been identified in stable disease after coronary angioplasty (2) but also in patients with infarcts reperfused by coronary angioplasty (3). The complete exploration of the epicardial and microvascular coronary vascularization is grouped under the name of the subspecialty: coronary physiology. Thus, an internationally recognized algorithm for exploring coronary physiology has been published (4). However, this algorithm is still little followed. The PRINCIPE registry aims to assess the prevalence of CMVD with the use of a standardized algorithm for exploring coronary physiology by coronary angiography in our center in current practice.

Clinical Trial Description


Study Design

Related Conditions & MeSH terms

NCT number NCT04560829
Study type Observational [Patient Registry]
Source University Hospital, Grenoble
Contact Gilles Barone Rochette, MD PhD
Phone +33476768888
Status Recruiting
Start date September 13, 2021
Completion date May 2023

See also
  Status Clinical Trial Phase
Withdrawn NCT04069234 - Study in Diabetes Mellitus Patients Without Prior Myocardial Infarction or Stroke Undergoing Elective Percutaneous Coronary Intervention. Phase 3
Terminated NCT04614467 - A Placebo-Controlled Trial of CLBS16 in Subjects With Coronary Microvascular Dysfunction Phase 2
Terminated NCT03236311 - A Dose Titration Study to Assess the Effects of SAR407899 in Patients With MVA and/or Persistent Stable Angina Despite Angiographically Successful PCI Phase 2
Recruiting NCT04598308 - EUROpean Coronary microCirculatory Resistance and Absolute Flow Trial
Recruiting NCT04541797 - Stress Cardiac Magnetic Resonance of Asymptomatic Type 2 Diabetics With Cardiovascular High Risk to Measure Empagliflozin Impact on Myocardial Blood Flow (CATCH-EM) N/A
Active, not recruiting NCT05197361 - Microvascular Coronary Resistance and Absolute Coronary FLOW in Patients With Percutaneous Intervention of a Chronic Total Occlusion
Recruiting NCT04827498 - Myocardial Ischemia Without Obstructive Coronary Stenoses
Suspended NCT05756088 - Determining the Association of Microvascular Disease as Assessed by PET and Graft Injury by Donor Derived Cell Free DNA
Recruiting NCT03217227 - Evaluating Myocardial Ischemia in Chest Pain Using Exercise CMR
Completed NCT03462017 - Pharmacodynamic Study to Assess the Effects of Repeated Dosing of SAR247799 on Endothelial Function in Patients With Type 2 Diabetes Mellitus Phase 1
Not yet recruiting NCT05492110 - Coronary Sinus Reducer Implantation in Patients With Ischaemia and Non-obstructed Coronary Arteries and Coronary Microvascular Dysfunction. N/A
Recruiting NCT04131075 - The Cerebral-Coronary Connection (C3) Study
Completed NCT04485234 - Inclusive Invasive Physiological Assessment in Angina Syndromes Registry
Completed NCT05471739 - Simultaneous Assessment of Coronary Microvascular Dysfunction and Ischemia With Non-obstructed Coronary Arteries With Intracoronary Electrocardiogram and Intracoronary Doppler
Completed NCT05406297 - Impact of TMAO Serum Levels on Hyperemic IMR in STEMI Patients
Completed NCT03907722 - The 3q25 rs2305619 Polymorphism Associates With Microvascular Obstruction in STEMI
Active, not recruiting NCT05034224 - Coronary Sinus Pressure and Microvascular Disease N/A
Active, not recruiting NCT05058833 - Prognostic Impact of Cardiac Diastolic Function and Coronary Microvascular Function